Patientenzugang
Three questions to Markus Isenmann, Country Lead Sanofi Switzerland
Read more
Press release: One in three new innovative medicines not submitted for reimbursement by health insurance companies
Read more
3 questions to our new board member: Jérome Garcin, General Manager for Switzerland and Austria bei Bristol Myers Squibb
Read more
Access to innovative medicines: Switzerland continues to stagnate behind Germany
Read more
3 to our new Board members: Florian Schick President Merck Switzerland
Read more
3 questions to the new Interpharma Board members: Anne Mette Wiis Vogelsang, CVP & General Manager Novo Nordisk Switzerland
Read more
3 questions to our new board member: Dimitri Gitas General Manager Switzerland – MSD
Read more
